NEKTAR THERAPEUTICSNKTR

Market cap
$334.8M
P/E ratio
Dec 31,
2011
Dec 31,
2012
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Product sales-------2120182420
Royalty revenue-------424131--
Non-cash royalty revenue related to the sales of future royalties-------3336497870
License, collaboration and other revenue-------1,097175602
Total revenue71811492012311653081,19311515310292
Cost of goods sold-------2421192522
Research and development127149190148183204268400435409400218
General and administrative47424141434452819910512392
Impairment Of Assets And Other Costs For Terminated Program---------45-136
Total operating costs and expenses195222269217260278367505555578548468
Loss from operations-124-141-120-16-29-113-60688-440-425-446-376
Liabilities, Fair Value Adjustment-----------833
Non-cash interest expense on liabilities related to the sales of future royalties---6182102120142167197244273
Loss on revaluation of liability related to the sale of future royalties-----------24-
Other Nonoperating Income (Expense)-110122538461837
Interest expense1015181818222222217--
Total non-operating income (expense), net-9-30-40-38-51-40-36-5-0-19-7711
Loss before provision for income taxes-133-171-160-54-81-153-96683-440-444-523-365
Provision for income taxes102-111111013
Net loss-134-172-162-54-81-154-97681-441-444-524-368
Earnings Per Share, Basic-------4.02-2.52-2.49-2.86-1.97
Earnings Per Share, Diluted-------3.78-2.52-2.49-2.86-1.97